Diabetes Center Berne @ BEA

Diabetes Center Berne @ BEA

Diabetes Center Berne @ BEA

DCB joined the Focus Day at BEA in Bern, an event highlighting the latest in healthcare innovation. It was a great opportunity to showcase how Diabetes Center Berne is advancing projects that turn research into practical solutions for improving diabetes care.

DC Berne BEA

Speakers and participants had a great time at the Focus Day at BEA in Bern last Saturday! The event at the new Festhalle brought together innovators from across healthcare, with a spotlight on how we can improve patient care and drive digital medicine forward.

A highlight for DCB was the presentation of CEO Derek Brandt, who shared the vision of Diabetes Center Berne. He emphasized how we are committed to improving the lives of people with diabetes through our cutting-edge translational projects.

It was inspiring to be part of such a forward-thinking event, where healthcare leaders like Christoph Ammann, Simon Rothen, and others shared their insights on the future of medicine in Bern. A big thank you to everyone who contributed to making this event a success!

More recent news

Sign up for our newsletter and stay up to date.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Switzerland

Revolutionizing Diabetes Care: How Your Idea Can Make a Global Impact

Revolutionizing Diabetes Care: How Your Idea Can Make a Global Impact

Revolutionizing Diabetes Care: How Your Idea Can Make a Global Impact

For the fifth time, the Diabetes Center Berne is launching the Open Innovation Challenge with the aim of specifically promoting innovative projects in the field of diabetes management on Swiss and international level. Participating innovtors benefit from professional expert feedback, and the five best projects receive access to a bootcamp. The finalists will receive prize money of up to USD 100,000 and further support from the DCB.

Transform Diabetes Care: Your Innovation Could Change Lives

More than 537 million people worldwide live with diabetes, facing daily challenges in managing their condition. Technological innovations have played a crucial role in simplifying diabetes management.

The DCB Open Innovation Challenge, launched in 2021, aims to bridge these gaps by fostering translational research in diabetes technology. Our goal is to identify groundbreaking solutions that enhance the quality of life for those affected by diabetes. Whether you’re a researcher, healthcare professional, start-up founder, or someone living with diabetes, your ideas are invaluable. Weโ€™re seeking diverse perspectives and innovative solutions to push diabetes technology forward.

Join and benefit

Following the initial selection phase, the Top 15 teams will enter a mentoring program with expert guidance. From there, the Top 5 teams will be chosen to participate in an exclusive Bootcamp in Switzerland (September 8โ€“11, 2025), where they will receive tailored coaching, mentoring, and media training.

Additionally, finalists will have the opportunity to present their ideas at the DTM Meeting in the USA from October 27-30, 2025. This event offers a fantastic chance to gain exposure in the USA, thanks to our ongoing collaboration with the Diabetes Technology Society.

Finally, the competition will culminate at the Day of Innovation & Award Ceremony in Bern, Switzerland (November 5, 2025), where an international expert jury will select the winning project.

The winning project will be selected by an international expert jury and rewarded with USD 100,000 in funding and in-kind support โ€“ making the DCB Open Innovation Challenge the worldโ€™s largest diabetes technology award with international appeal. You will get access to a global network of experts from the field โ€“ all while your idea remains entirely yours.

Don’t miss this opportunity to turn your innovation into reality.

Submit your idea by April 30, 2025, on our innovation platform: innovation.dcberne.com

More recent news

Sign up for our newsletter and stay up to date.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Switzerland

SNAQ Launches AI-Powered Glucose Prediction feature

SNAQ Launches AI-Powered Glucose Prediction feature

SNAQ Launches AI-Powered Glucose Prediction feature

SNAQ has introduced a groundbreaking AI-driven feature that predicts glucose responses before meals, revolutionizing diabetes care.

The new meal glucose prediction tool allows CGM users to anticipate their body’s reaction to food using a proprietary deep learning model and a unique digital twin approach. This innovation offers highly personalized insights for improved glucose control.

SNAQ also secured new funding led by the Diabetes Venture Fund at Serpentine Ventures, reinforcing investor confidence despite a tough market. CEO Aurelian Briner emphasized the companyโ€™s commitment to scaling innovations and transforming diabetes care. Looking ahead, SNAQ plans to introduce more AI-driven advancements to empower individuals in managing their health.

For more details, read the full press release or visit SNAQโ€™s website to learn more about their innovations in diabetes care.

More recent news

Sign up for our newsletter and stay up to date.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Switzerland

DCB featured in Finanz und Wirtschaft – Health & Wealth 3/2025

DCB featured in Finanz und Wirtschaft – Health & Wealth 3/2025

DCB featured in Finanz und Wirtschaft – Health & Wealth 3/2025

Discover how DCB leads the way in diabetes technology through its innovative collaborations and community-focused research, as featured in the special issue ofย Finanz und Wirtschaft.

DCB in Finanz und Wirtschaft special

A unique aspect of DCB is its close collaboration with the diabetes community, integrating their needs and experiences into research and development processes. DCB also partners with international research and industry organizations to enhance healthcare efficiency and improve the quality of life for people with diabetes.

On the right, you can download the entire article in German.

More recent news

Sign up for our newsletter and stay up to date.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Switzerland

Meet us at ATTD!

Meet us at ATTD!

Meet us at ATTD!

The ATTD congress in Amsterdam is just around the corner and different members of the DCB team will be on-site. Meet us there to discuss our services, potential collaborations or just chat over a coffee!

DCB at ATTD 2025

The ATTD (Advanced Technologies & Treatments in Diabetes) congress is the leading international meeting point for all those involved and interested in diabetes technology. DCB is thrilled to participate in this prestigious event in Amsterdam fostering connections with like-minded enthusiasts dedicated to diabetes technology, innovation, and research.

We will be present with different members of our team from different divisions. Additionally, members of our Lived Experience Panel will also be attending. We are looking forward to attending insightful Scientific sessions, exploring new innovative solutions and above all: networking with, you!

Also, we are excited to participate in ATTD Ignite 2025, an exclusive platform designed to foster innovation and collaboration in diabetes technology. This event, taking place on March 19, 2025, from 09:00 to 13:00 in Hall C, provides a unique opportunity for startups and researchers to connect, share insights, and accelerate breakthroughs in diabetes care. Greta Ehlers, Business Scouting & Development at DCB, will be speaking in the session โ€œEmpowering Startups for Successโ€ from 09:05 to 10:00, where key topics such as funding strategies, pitch refinement, and global expansion will be discussed. Donโ€™t miss this opportunity to gain valuable insights and engage with industry experts!

If you are attending ATTD and are eager to learn more about our services, the Open Innovation Challenge, our main research areas, our community, or any other topics โ€“ please reach out to those attending and book a coffee slot. We look forward to connecting with you!

Unable to attend ATTD but curious about our services and activities? We would also be happy to schedule calls for after the conference to discuss potential collaborations. Feel free to reach out to individual members of our team.

Downloads

Book a coffee with us!

Hanne Ballhausen

Project Manager Innovation

Book a Coffee Slot

Dr. Maren Schinz

Project Lead Insulin Activity

Book a Coffee Slot

Greta Ehlers

Business Development

Send an E-Mail

More recent news

Sign up for our newsletter and stay up to date.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Switzerland

DCB featured in Sonntagszeitung – Gesundheitsguide 12/2024

DCB featured in Sonntagszeitung – Gesundheitsguide 12/2024

DCB featured in Sonntagszeitung – Gesundheitsguide 12/2024

Dive into the latest edition of Sonntagszeitung Gesundheitsguide and find out why DCB is global leader in diabetes technology.

DCB innovative Technologies highlighted in latest Sonntagszeitung edition

Our DCB Start-up Night and especially this years winner “IMS” were featured in this publication.

IMS was able to persuade our expert jury with an revolutionary device for glucose measurement. The Start-up Beep Insights was awarded a Public Choice Award for their Beep-App helping to estimate insulin resistance.
We are also supporting Inhouse-Projects like for example Beyond Diagnostics that aims to improve the safety of therapy for people with diabetes.ย 

Do you have an idea in the are of diabetes technology? Feel free to contact us!ย 

For more details, explore the latest below embedded edition Sonntagszeitung 12 / 2024.

The full article is available in German.

More recent news

Sign up for our newsletter and stay up to date.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Switzerland